Epigenetics in oral squamous cell carcinoma
- PMID: 28932035
- PMCID: PMC5596676
- DOI: 10.4103/jomfp.JOMFP_150_17
Epigenetics in oral squamous cell carcinoma
Abstract
Oral squamous cell carcinoma (OSCC) is the most common type of oral neoplasm, accounting for over 90% of all oral malignancies and 38% of head and neck tumors. Worldwide, OSCC is the eighth most common human cancer, with more than 500,000 new cases being diagnosed every year with a fairly onerous prognosis, encouraging further research on factors that might modify disease outcome. Genetic and/or environmental risk factors associated with the development of oral cancer have been sufficiently understood (smoking, alcohol, betel, diet, living habits, etc.). Knowledge of the genetic basis in oral carcinogenesis is still a challenging task. To improve the diagnosis and prevention, a previously unknown type of chromatin modification, known as epigenetic, which is defined as heritable DNA changes that are not encoded in the sequence itself and which are reversible and increasingly appear to serve fundamental roles in cell differentiation and development are studied. Tumors shed their DNA into the blood and epigenetic changes that occur early during tumorigenesis, sometimes even in premalignant lesions, can provide valuable biomarkers. Key components involved in epigenetic regulation are DNA methylation, histone modifications and modifications in micro ribonucleic acids (miRNAs). Epigenetic modifications may contribute to aberrant epigenetic mechanisms seen in oral precancers and cancers. In the near future, epigenetic variations found in oral dysplastic cells can act as a molecular fingerprint for malignancies.
Keywords: Carcinogenesis; DNA; epigenetics; methylation; oral squamous cell carcinoma.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Epigenetics: A possible answer to the undeciphered etiopathogenesis and behavior of oral lesions.J Oral Maxillofac Pathol. 2016 Jan-Apr;20(1):122-8. doi: 10.4103/0973-029X.180967. J Oral Maxillofac Pathol. 2016. PMID: 27194874 Free PMC article. Review.
-
Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review.Cancers (Basel). 2023 Nov 27;15(23):5600. doi: 10.3390/cancers15235600. Cancers (Basel). 2023. PMID: 38067304 Free PMC article. Review.
-
Epigenetics of oral and oropharyngeal cancers.Biomed Rep. 2018 Oct;9(4):275-283. doi: 10.3892/br.2018.1136. Epub 2018 Jul 27. Biomed Rep. 2018. PMID: 30233779 Free PMC article. Review.
-
Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.Int J Mol Sci. 2017 Jul 12;18(7):1506. doi: 10.3390/ijms18071506. Int J Mol Sci. 2017. PMID: 28704968 Free PMC article. Review.
-
Global analysis of DNA methylation changes during progression of oral cancer.Oral Oncol. 2013 Nov;49(11):1033-42. doi: 10.1016/j.oraloncology.2013.08.005. Epub 2013 Sep 13. Oral Oncol. 2013. PMID: 24035722
Cited by
-
Profiling of Mitochondrial DNA Heteroplasmy in a Prospective Oral Squamous Cell Carcinoma Study.Cancers (Basel). 2020 Jul 17;12(7):1933. doi: 10.3390/cancers12071933. Cancers (Basel). 2020. PMID: 32708892 Free PMC article.
-
Chemopreventive and Biological Strategies in the Management of Oral Potentially Malignant and Malignant Disorders.Bioengineering (Basel). 2024 Jan 9;11(1):65. doi: 10.3390/bioengineering11010065. Bioengineering (Basel). 2024. PMID: 38247942 Free PMC article. Review.
-
Long non-coding RNAs in Oral squamous cell carcinoma: biologic function, mechanisms and clinical implications.Mol Cancer. 2019 May 27;18(1):102. doi: 10.1186/s12943-019-1021-3. Mol Cancer. 2019. PMID: 31133028 Free PMC article. Review.
-
A non-toxic, reversibly released imaging probe for oral cancer that is derived from natural compounds.Sci Rep. 2021 Jul 7;11(1):14069. doi: 10.1038/s41598-021-93408-0. Sci Rep. 2021. PMID: 34234213 Free PMC article.
-
Connecting the dots: investigating the link between environmental, genetic, and epigenetic influences in metabolomic alterations in oral squamous cell carcinoma.J Exp Clin Cancer Res. 2024 Aug 21;43(1):239. doi: 10.1186/s13046-024-03141-5. J Exp Clin Cancer Res. 2024. PMID: 39169426 Free PMC article. Review.
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
-
- Stewart BW, Greim H, Shuker D, Kauppinen T. Defence of IARC monographs. Lancet. 2003;361:1300. - PubMed
-
- Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48:3282–7. - PubMed
-
- Lingen MW, Pinto A, Mendes RA, Franchini R, Czerninski R, Tilakaratne WM, et al. Genetics/epigenetics of oral premalignancy: Current status and future research. Oral Dis. 2011;17(Suppl 1):7–22. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources